SK Pharmteco to expand Irish campus
Submitted by:
Andrew Warmington
SK Pharmteco has announced a two-phase, $35 million investment to boost both capacity and capabilities
Genomatica and Unilever to scale bio alternatives
Submitted by:
Andrew Warmington
Unilever and Genomatica have launched a $120 million venture to scale up and commercialise plant-based
Piramal progresses two API sites
Submitted by:
Andrew Warmington
Piramal Pharma Solutions (PPS) has announced the implementation of “various tools to unlock API manufacturing
Charitable appeal – Sabin Metal helping orphans and Ukrainian refugees
Submitted by:
Andrew Warmington
Through the Andrew Sabin Family foundation, precious metal recycler Sabin Metal is sponsoring the construction
Two zinc chemical firms combined
Submitted by:
Andrew Warmington
Private equity firm Aterian Investment Partners has acquired EverZinc and will combine it with existing
RAC: No change to glyphosate classification
Submitted by:
Andrew Warmington
The EU’s Risk Assessment Committee has assessed glyphosate’s hazardous properties against criteria in the Classification
Feature article: Creating a participation-based safety culture
Submitted by:
Andrew Warmington
Sarah Ingle, who specialises in chemical safety and regulatory compliance at EcoOnline, explores
Olon begins R&D centre
Submitted by:
Andrew Warmington
Italian CDMO Olon is to invest €10 million to create an R&D hub at its
JM sells Battery Materials
Submitted by:
Andrew Warmington
Johnson Matthey (JM) has exited from the batteries market by selling most of its Battery
Cepsa to stay in chemicals
Submitted by:
Andrew Warmington
Spanish energy giant Cepsa has decided to retain its Chemicals division, Cepsa Química, after completing